🇰🇷 Ocupress in South Korea

Ocupress (CARTEOLOL) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

Ocupress in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Cardiovascular approved in South Korea

Frequently asked questions

Is Ocupress approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for Ocupress in South Korea?

Marketing authorisation holder not available in our data.